Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Emotion Builder: An Intervention for Emotional Deficits After Brain Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02432300
Recruitment Status : Completed
First Posted : May 4, 2015
Results First Posted : November 22, 2017
Last Update Posted : November 22, 2017
Sponsor:
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Dawn Neumann, Indiana University

Brief Summary:
The purpose of this study is to examine a web-based training program for treating emotional problems in people who have suffered a traumatic brain injury (TBI).

Condition or disease Intervention/treatment Phase
Traumatic Brain Injury Alexithymia Behavioral: Emotion Builder Not Applicable

Detailed Description:
This is a pilot study to examine how subjects with TBI feel about the virtual reality program as a treatment and to assess the effectiveness of the virtual reality program at increasing subjects' awareness and understanding of emotions.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 17 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Emotion Builder: An Intervention for Emotional Deficits After Brain Injury
Study Start Date : May 2015
Actual Primary Completion Date : June 2016
Actual Study Completion Date : June 2016

Arm Intervention/treatment
Experimental: Intervention
Treatment sessions with a virtual treatment program called Emotion Builder
Behavioral: Emotion Builder
Total of 8 therapy sessions with the Emotion Builder over approximately four (4) weeks (2 sessions a week)




Primary Outcome Measures :
  1. Toronto Alexithymia Scale-20 (TAS-20) [ Time Frame: Week 6 ]
    This is a 20-item self-report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing Feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher alexithymia). Subscales are summed to compute a total score Scores between 52 and 60 indicate moderate alexithymia; scores 61 and higher indicate high alexithymia.

  2. Levels of Emotional Awareness Scale (LEAS) [ Time Frame: Week 6 ]
    The LEAS is comprised of ten hypothetical scenarios that are three or four sentences in length. Participants must respond how they think they would feel and how another person would feel in response to the hypothetical scenario. The more discrete emotions (e.g., bad vs sad) receive higher points, as well as blended emotions (e.g. sad and angry). There are 10 items on this measure. The minimum score for each item is 0 and the max score for each item is 5. The item scores are summed to calculate a total score. Thus, the total scores range from 0-50; 0=lowest awareness and 50=highest awareness. A computerized scoring system and parallel forms were used.


Secondary Outcome Measures :
  1. Patient Health Questionnaire-9 (PHQ-9) as an Assessment of Depression [ Time Frame: Week 6 ]
    The PHQ-9 is a self-report questionnaire designed to assess depression through nine questions that come directly from the DSM-IV signs and symptoms of major depression. The 9 items describe problems associated with depression, and participants must rate how often they have been bothered by the problems in the last 2 weeks on a 0-3 scale. The scores are summed for a total depression score, ranging from 0-27, which higher scores indicating greater depression.

  2. State Trait Anxiety Inventory (STAI) [ Time Frame: Week 6 ]
    The STAI is a self-report measure of state and trait anxiety (20 items each). The trait anxiety subscale was the variable of interest for this study. Higher scores indicate more trait or state anxiety. Scores for each scale range from 20-80, with higher scores indicating greater anxiety. The raw scores were converted into T scores using age and gender norms provided by the authors for the STAI. A score of 50 represents the mean. A difference of 10 from the mean indicates a difference of one standard deviation. Higher T scores were still indicative of higher anxiety. We reported T scores for trait anxiety.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • TBI (injury due to an external physical force);
  • Moderate to severe TBI, defined either by74 Glasgow Coma Score at time of injury (≤12), or post-traumatic amnesia (≥1 day), or loss of consciousness (≥30 minutes);
  • ≥1 year post-injury;
  • between 18-65 years old;
  • Have a moderate to high alexithymia score (≥52) on the TAS-2070 at screening.

Exclusion criteria:

  • Diagnosed with pre-morbid neurological disorders (e.g. stroke, autism, alzheimer's disease, Parkinson's disease);
  • Formerly diagnosed with a developmental disability;
  • Pre-morbid diagnosis of major psychiatric disorders (e.g. schizophrenia);
  • Unable to follow directions;
  • Uncorrected visual or hearing impairments that would prevent sufficient task participation;
  • No access to reliable transportation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02432300


Locations
Layout table for location information
United States, Indiana
Indiana University Health Facilities
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
EmotEd
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Layout table for investigator information
Principal Investigator: Dawn Neumann, PhD Indiana University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Dawn Neumann, Assistant Research Professor, Department of Physical Medicine and Rehabilitation, IU School of Medicine, Indiana University
ClinicalTrials.gov Identifier: NCT02432300    
Other Study ID Numbers: 1R41HD077967-01A1 ( U.S. NIH Grant/Contract )
1404681990 ( Other Identifier: Institutional Review Board (IRB) )
1R41HD077967-01A1 ( U.S. NIH Grant/Contract )
First Posted: May 4, 2015    Key Record Dates
Results First Posted: November 22, 2017
Last Update Posted: November 22, 2017
Last Verified: November 2017
Keywords provided by Dawn Neumann, Indiana University:
Traumatic Brain Injury
Alexithymia
Emotions
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Wounds and Injuries
Affective Symptoms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Behavioral Symptoms